home / stock / bcyc / bcyc news

BCYC News and Press, Bicycle Therapeutics plc From 07/01/19

Stock Information
Company Name: Bicycle Therapeutics plc
Stock Symbol: BCYC
Market: NYSE
Website: bicycletherapeutics.com
Menu
BCYC BCYC Quote BCYC Short BCYC News BCYC Articles BCYC Message Board
Get BCYC Alerts

News, Short Squeeze, Breakout and More Instantly...
BCYC - Bicycle Therapeutics up 10% premarket on positive THR-149 data

Thinly traded micro cap Bicycle Therapeutics (NASDAQ: BCYC ) is up  10%  premarket on light volume on the heels of encouraging data from an open-label Phase 1 clinical trial evaluating a single intravitreal injection of THR-149, a Bicycle-based plasma kallikrein inhibitor, in pat...
BCYC - Bicycle Therapeutics Announces Positive Topline Results from Oxurion's Phase I Trial Using a Novel Bicycle-based Plasma Kallikrein Inhibitor for the Treatment of Diabetic Macular Edema

Phase I results provide additional clinical activity data for Bicycles Bicycle Therapeutics , a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide ( Bicycle® ) technology, today announced the successful completion of Oxurion...

BCYC - Midday Gainers / Losers

Gainers: Axovant Gene Therapies (NASDAQ: AXGT ) +40% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +24% . India Globalization Capital (NYSEMKT: IGC ) +17% . Pintec Technology (NASDAQ: PT ) +14% . ObsEva SA (NASDAQ: OBSV ) +12% . Overstock.com (NASDAQ: OSTK ) +12% . Fuwei Films (NASDAQ...

Previous 10 Next 10